Skip to content

Optimization and clinical Application of the Diagnosisand and Management of Heart Failure in Patients Post-Myocardial Infarction (OCEAN)

Optimization and clinical Application of the Diagnosisand and Management of Heart Failure in Patients Post-Myocardial Infarction (OCEAN)

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500101102
Enrollment
Unknown
Registered
2025-04-21
Start date
2025-04-30
Completion date
Unknown
Last updated
2025-05-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Heart failure

Interventions

Group A (patients with heart failure after in-hospital myocardial infarction):None
Group B (patients with in-hospital MI and out-of-hospital heart failure within 1 year):None
Group C (patients with in-hospital MI and no heart failure within 1 year):None

Sponsors

Langfang People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1.Age >= 18 years; 2.Diagnosis of STEMI or NSTEMI according to the 2023 ESC ACS Guidelines; 3.First-time hospitalization for STEMI or NSTEMI; 4.Signed informed consent obtained from the patient.

Exclusion criteria

Exclusion criteria: 1. Patients with a history of heart failure before admission; 2. Patients have moderate to severe liver dysfunction (alanine aminotransferase and/or aspartate aminotransferase > 2 times the upper limit of normal); 3. Dialysis-dependent renal failure; 4. Have participated or are participating in other intervention studies related to heart failure after myocardial infarction; 5. Inability to cooperate with the study due to mental illness or cognitive impairment; 6. Pregnant or lactating women.

Design outcomes

Primary

MeasureTime frame
Definitively diagnosed in-hospital heart failure;1-year composite endpoint of all-cause mortality and heart failure rehospitalization post-discharge;

Secondary

MeasureTime frame
Major Adverse Cardiovascular and Cerebrovascular Events (MACCE);Cardiac death;Myocardial infarct;Stroke;Revascularization;All-cause Readmission;Cardiac Readmission;Heart Failure Readmission;Bleeding;

Countries

China

Contacts

Public ContactXue Zengming

Langfang People's Hospital

xuezengming@613.com+86 180 0336 8127

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026